The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
_
Topics
Meeting category
Date(s)
14 May 2024 - 17 May 2024
Program Language
English, French
Location
Cotonou,
Benin
Meeting type
In-Person Meeting
INTEREST 2024
Related Enduring Materials
Enduring Materials
Session 1: Opening of the Conference -
The Road to 95-95-95: Progress in HIV Prevention and Treatment Scale-up in Sub-Saharan Africa
Current Status of HIV in Benin
Session 2: Emerging and Re-Emerging Diseases - 3rd James Hakim Memorial Lectures -
Didier Koumavi Ekouevi, MD, PhD
Interrupting the Unending Cycles of Emerging and Re-Emerging Diseases Outbreaks - A Possibility or Pipe Dream!
HIV-2
Université de Lomé, Centre de Formation et de Recherche en Santé Publique, Togo
Session 3: Tuberculosis / Elimination of Malaria in Africa -
Disseminated HIV-Associated TB and the Treatment
Sonographic Patterns of TB – The FASH Scan
Malaria Elimination in Africa: Challenges & Perspectives
Session 4: Debate - Resolved: PEPFAR and the Global Fund Should Expand Their Missions Now to Fund Screening, Prevention, and Treatment of Non-Communicable Diseases -
First Speaker For the Proposition
First Speaker Against the Proposition
Second Speaker For the Proposition
Second Speaker Against the Proposition
Session 5: HIV Prevention Technologies -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Combination Prevention and Contraception - State of the Science
New Prevention Technologies - From Research Findings to Access
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
Session 6: HIV in Benin -
Overview of the HIV Response and Management in Benin
Paediatric HIV and Transition from Adolescent to Adult Sites in Benin
HIV Response Within the Key Populations in Benin: Lessons Learned, Challenges, and Perspectives
Session 7: HIV Vaccines and Cure -
Progress Towards HIV Cure
Session 8: Structural Barriers in HIV -
Vanessa Apea, MBBS, MPH, FRCP, DipGUM, DFSRH
HIV and Gender
HIV Stigma: Getting to 10%
Barts Health NHS Trust / Queen Mary University of London, United Kingdom
Session 9: Vertical Transmission of HIV -
Eliminating HIV in Children - Why is Africa Behind?
Session 10: HIV and Children and Adolescents -
Sabrina Bakeera-Kitaka, MD, PhD
Treatment Optimization in Children Including Infants
Differentiated Service Delivery among Adolescents and Young Adults
Makerere University College of Health Sciences / Mulago National Referral Hospital, Uganda
Session 11: Care and Treatment -
Charles Kouanfack, MD, PhD
Diagnosis and Management of Cryptococcal Meningitis
University of Dschang / University Teaching Central Hospital Yaoundé, Cameroon
Management of Second Line ART in Sub-Saharan Africa
Session 12: HIV & Cervical Cancer (HIV and Comorbidities I) -
Sabrina Bakeera-Kitaka, MD, PhD
Overview of the Burden of HPV in PLWHIV
Makerere University College of Health Sciences / Mulago National Referral Hospital, Uganda
The Integration of HPV Vaccination within HIV Guidelines
Session 13: HIV & Comorbidities II -
Ntobeko Ntusi, BSc(Hons), MBChB, MD, DPhil
HIV & Cardiometabolic Disorders
Groote Schuur Hospital / University of Cape Town, South Africa
Beyond Surviving to Thriving for All Adolescents Living with HIV
Mini-Oral Abstract Presentations V -
#25 - Profil de Mutation de Résistance Aux Inhibiteurs Nucléosidiques de la Transcriptase Inverse Chez Les Enfants ET Adultes en éChec Virologique en Côte D’Ivoire Dans Un Contexte de Basculement Systématique Sous Une Combinaison à Base de Dolutégravir
Jean-Jacques Renaud Dechi
Côte d'Ivoire
Session 14: Health Systems Strengthening -
Glenda E. Gray, MBBCH, FCPaeds (SA), DSc
ANRS MIE
North and South Research Partnership
South African Medical Research Council (SAMRC), South Africa
Access to Innovative Biomedical Treatment and Prevention Tools in Low- and Middle-Income Countries
Session 15: Intersection of HIV Prevention and Treatment -
Update on Long Acting ART for PrEP and Treatment
General
What's New
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Official Conference Website
Welcome
INTEREST 2024 took place from 14-17 May 2024 as a live meeting in Cotonou, Benin.
The annual INTEREST Conference is the premier scientific conference for HIV in Africa, and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference showcases cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of HIV-1 acquisition. It continues to foster a community of African physicians and scientists to facilitate the implementation of local solutions for the management of people living with HIV and for the prevention of HIV transmission.
INTEREST is co-organised by Amsterdam Institute for Global Health and Development (AIGHD) and Virology Education.
Conference Chairs
General Information
Past Conferences
2007 – Kampala, Uganda
2008 – Dakar, Senegal
2009 – Lusaka, Zambia
2010 – Maputo, Mozambique
2011 – Dar Es Salaam, Tanzania
2012 – Mombasa, Kenya
2013 – Dakar, Senegal
2014 – Lusaka, Zambia
2015 – Harare, Zimbabwe
2016 – Yaounde, Cameroon
2017 – Lilongwe, Malawi
2018 – Kigali, Rwanda
2019 – Accra, Ghana
2020 – Windhoek, Namibia (Virtual Conference)
2021 – Virtual Conference
2022 – Kampala, Uganda
2023 - Maputo, Mozambique
2008 – Dakar, Senegal
2009 – Lusaka, Zambia
2010 – Maputo, Mozambique
2011 – Dar Es Salaam, Tanzania
2012 – Mombasa, Kenya
2013 – Dakar, Senegal
2014 – Lusaka, Zambia
2015 – Harare, Zimbabwe
2016 – Yaounde, Cameroon
2017 – Lilongwe, Malawi
2018 – Kigali, Rwanda
2019 – Accra, Ghana
2020 – Windhoek, Namibia (Virtual Conference)
2021 – Virtual Conference
2022 – Kampala, Uganda
2023 - Maputo, Mozambique
Abstract Submission
The Abstract Submission Portal for INTEREST 2024 will open soon.
Practical Information
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants that have successfully completed the post-conference survey.
Language
The official language of the conference is English. French translation will be available.
Conference Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Support
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV treatment, pathogenesis, and prevention research.
This collaboration plays a vital role in both the organisational as well as scientific success of the programme.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact either
Karin Siebelt at Karin.Siebelt@amededu.com or call +31 30 230 7147, or
Marloes Nijboer at m.nijboer@aighd.org
Benefits of Support
By supporting this programme, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this programme.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the programme
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the programme book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Media
INTEREST 2022
AIDSMap reviewed the INTEREST 2022 Conference, highlighting sessions such as those on global health targets, vaginal rings & topical PrEP, HIV treatment in pregnancy, and more.
Read their article here.
Language
Related Programs
